Services - clinical_monitoring
DOT handles all aspects of clinical trials from Phase I to Phase IV. Our monitors are highly educated and well experienced within various therapeutic areas. Our senior managers all have more than 10 years of clinical experience, including global trials. With our capable and knowledgeable monitors, we are always able to cultivate good relationships between the sites and our clients which makes our trials run smoothly and efficiently.
We always perform an optimum monitoring model for our clients with the guarantee of data quality and overall cost effectiveness.
- Special Population Groups
- Investigators-initiated Studies
- Observational Studies
- Medical device Studies
The following is a summary of our Therapeutic Experience:
Scroll horizontally ↔
| Description | Phase | Subjects No. | Population | Route of Administration | |
|---|---|---|---|---|---|
| Cardiovascular | A trial to evaluate risk factors for occurrence of Acute Coronary Syndrome. | Registry | 9000 | Patients with Cardiovascular disease | - |
| Neurosurgery | A trial to evaluate the stent treatment for Cerebral Artery Stenosis. | 3 | 20 | Patients with Cerebral Artery Stenosis | Implantation (Device) |
| Neurology | A trial of a drug for Schizophrenia. | 2a | 10 | Schizophrenia Patients | Oral |
| A trial to evaluate the efficacy and safety of a drug in Muscular Dystrophies. | 2 | 20 | Duchenne Muscular Dystrophies Patients | Injection | |
| A trial to evaluate a drug for Mitochondrial encephalomyopathy, Lactic acidosis, and Stroke-like episodes (MELAS). | 3 | 15 | MELAS Patients | Oral | |
| Oncology | A multi-center trial of a diagnostic drug for Bladder Cancer. | 3 | 60 | Patients with Bladder Cancer | Oral |
| A global trial of a stent system for the treatment of Pancreatic Cancer. | - | 40 | Patients with Resectable Pancreatic Cancer | Implantation (Device) |
|
| Urology | A multi-center trial to evaluate the efficacy and safety of Overactive Bladder. | 2 | 600 | Patients with Overactive Bladder | Transdermal |
| A double-blind evaluation trial of a drug for Overactive Bladder. | 3 | 1000 | Patients with Overactive Bladder | Transdermal | |
| A long-term safety evaluation trial of a drug for Overactive Bladder. | 3 | 300 | Patients with Overactive Bladder | Transdermal | |
| A multi-center trial to evaluate the efficacy and safety of Benign Prostatic Hyperplasia (BPH). | 2 | 600 | BPH Patients | Oral | |
| Gynecology | A multi-center trial to evaluate a drug for Infertility. | 3 | 100 | Infertility Female Patients | Injection |
| Orthopedics | A global bridging trial of a drug for Hand Surgery. | 3 | 100 | Patients with Dupuytren's disease | Injection |
| A trial to evaluate a prosthetic treatment for Rheumatism | - | 20 | Rheumatoid Arthritis Patients | Implantation (Device) |
|
| Endocrine | A global trial to evaluate the efficacy of a drug for Hyperlipidemia. | 3 | 150 | Patients with High Cholesterol Level | Injection |
| Hematology | A multi-center trial to evaluate the safety, pharmacokinetics and efficacy of a drug for Myelodysplastic Syndromes (MDS). | 2 | 11 | MDS Patients | Oral |
| A multi-center trial to evaluate the efficacy of a drug for Thrombotic Thrombocytopenic Purpura (TTP) | 2 | 6 | TTP Patients | Injection |
